G01N33/48

DISEASE DIFFERENTIATION SUPPORT METHOD, DISEASE DIFFERENTIATION SUPPORT APPARATUS, AND DISEASE DIFFERENTIATION SUPPORT COMPUTER PROGRAM

Disclosed is a disease differentiation support method for supporting disease differentiation, the disease differentiation support method including: obtaining a first parameter obtained by analyzing an image including a cell contained in a sample collected from a subject; obtaining a second parameter regarding a number of cells contained in the sample; and generating, by using a computer algorithm, differentiation support information for supporting disease differentiation, on the basis of the first parameter and the second parameter.

Rational drug design with computational free energy difference calculation using a modified bond stretch potential
11562808 · 2023-01-24 · ·

A method and system for calculating the free energy difference between a target state and a reference state. The method includes determining one or more intermediate states using a coupling parameter, performing molecular simulations to obtain ensembles of micro-states for each of the system states, and calculating the free energy difference by an analysis of the ensembles of micro-states of the system states. The method can be particularly suited for calculating physical or non-physical transformation of molecular systems such as ring-opening, ring-closing, and other transformations involving bond breaking and/or formation. A soft bond potential dependent on a bond stretching component of the coupling parameter and different from the conventional harmonic potential is used in the molecular simulations of the system states for the bond being broken or formed during the transformation.

IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, IMAGE PROCESSING PROGRAM, AND DIAGNOSIS SUPPORT SYSTEM

An image processing device 100 includes, in a case where designation of a plurality of partial regions corresponding to a cell morphology is received, the plurality of partial regions being extracted from a pathological image, a generation unit 154 that generates auxiliary information indicating information about a feature amount effective when a plurality of partial regions is classified or extracted with respect to a plurality of feature amounts calculated from the image; and in a case where setting information about an adjustment item according to the auxiliary information is received, an image processing unit 155 that performs an image process on the image using the setting information.

CONCENTRATION DEVICE, SAMPLE SOLUTION CONCENTRATION METHOD, SAMPLE SOLUTION EXAMINATION METHOD, AND EXAMINATION KIT

There are provided a concentration device for concentrating a sample solution, which makes it possible to obtain a sample solution concentrated solution having a desired concentration fold ratio, a sample solution concentration method using the concentration device, a sample solution concentration method using the sample solution examination method, and an examination kit including the concentration device. The concentration device is a concentration device for concentrating a sample solution which is an aqueous solution containing a high-molecular-weight molecule, the concentration device including a cylinder that accommodates a particulate super absorbent polymer and a piston that is insertable into the cylinder, where the cylinder has, at a bottom part, a liquid holding part for holding a part of the sample solution injected into the cylinder, the super absorbent polymer is accommodated in the cylinder to be in contact with the liquid holding part on the liquid holding part, and the piston includes the tip part having holes smaller than the particle diameter of the super absorbent polymer after water absorption.

Systems and methods for analyzing circulating tumor DNA
11560598 · 2023-01-24 · ·

The invention provides oncogenomic methods for detecting tumors by identifying circulating tumor DNA. A patient-specific reference directed acyclic graph (DAG) represents known human genomic sequences and non-tumor DNA from the patient as well as known tumor-associated mutations. Sequence reads from cell-free plasma DNA from the patient are mapped to the patient-specific genomic reference graph. Any of the known tumor-associated mutations found in the reads and any de novo mutations found in the reads are reported as the patient's tumor mutation burden.

Biometric system
11561165 · 2023-01-24 · ·

The biometric system comprises: a measurement cartridge; and a meter, equipped with the measurement cartridge, for measuring an analyte present in a sample of the measurement cartridge. The measurement cartridge comprises a reagent container, a capillary module, and a reagent rod. The reagent container receives a liquid reagent and has a top sealed with a sealing film. The capillary module comprises a capillary tube which is located on an upper side of the reagent container and collects the sample by a capillary phenomenon, and the capillary tube is introduced into the reagent container by rupturing a contact portion to the sealing film by an applied pressure.

Systems and methods for navigating to a target location during a medical procedure

The systems and methods of the present disclosure are used for guiding a medical instrument towards a target, the method positioning a medical instrument at a first location within a patient anatomy, wherein the medical instrument comprises at least one sensor, determining a first biomarker measurement using the at least one sensor, determining a second biomarker measurement using the at least one sensor, comparing the first biomarker measurement with the second biomarker measurement to determine a proximity to the target to provide a first comparison, and providing guidance for moving the medical instrument based on results of the first comparison.

Systems and methods for navigating to a target location during a medical procedure

The systems and methods of the present disclosure are used for guiding a medical instrument towards a target, the method positioning a medical instrument at a first location within a patient anatomy, wherein the medical instrument comprises at least one sensor, determining a first biomarker measurement using the at least one sensor, determining a second biomarker measurement using the at least one sensor, comparing the first biomarker measurement with the second biomarker measurement to determine a proximity to the target to provide a first comparison, and providing guidance for moving the medical instrument based on results of the first comparison.

Method for analyzing sulfide-based solid electrolyte using computer simulation and program for analyzing sulfide-based solid electrolyte using computer simulation

Disclosed is a method for analyzing a sulfide-based solid electrolyte using computer simulation including connecting, by a user, to a client accessible to a server, inputting information of a sulfide-based solid electrolyte to be analyzed to the client, transmitting, by the client, the information to the server, implementing, by the server, generation of a three-dimensional structure in which anion clusters and lithium ions are disposed, based on the transmitted information, feeding back, by the server, an implementation result to the client, and displaying, by the client, the feedback result. In addition, properties of sulfide-based solid electrolytes, which cannot be observed by experimentation, can be analyzed based on lithium, ion conductivity.

CHD risk stratification evaluations for subjects with high levels of large HDL-P
11703501 · 2023-07-18 · ·

Embodiments of the invention are directed to methods, systems and computer programs that provide improved risk stratification for people having elevated large HDL-P using at least one defined HDL risk interaction parameter.